Chemical Structure and When it was Licensed
Structure of a Hydantoin Molecule
This is the basic structure for a hydantoin molecule. Phenytoin, ethotoin, mephenytoin, and fosphenytoin all fall into the category hydantoin molecules and have been used as antiepileptic agents (Fig. 277-1 ).
Structure of a hydantoin molecule
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ANDA:
-
Abbreviated new drug application
- FDA:
-
Food and drug administration
References
Anderson G (1998) A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 32:554–563
Buchthal F, Svensmarkti O (1959) Aspects of the pharmacology of phenytoin (Dilantin®) and phenobarbital relevant to their dosage in the treatment of epilepsy. Epilepsia 1:373–384
Cerebyx® package insert (2001) Retrieved from http://www.fda.gov/cder/foi/label/2001/20450s4s5lbl.pdf
Elson LS, Penry JK (1981) Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. Epilepsia 22(4):467–473
FDA Center for Drug Evaluation and Research (FDA) (2009) Retrieved from http://www.accessdata.fda.gov/scripts/cder/drugsatfda/
French JA et al. (2004) Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Neurology 62:1252–1260
French J, Ben-Menachem E (2007) Chapter 135: overview antiepileptic drugs. In: Engel J, Pedley A (eds) Epilepsy: a comprehensive textbook, 2nd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 1431–1432
Lund M, Jorgensen RS, Kühl V (1964) Serum diphenylhydantoin (phenytoin) in ambulant patients with epilepsy. Epilepsia 5(1):51–58
Peganone® package insert (2007) Retrieved from http://www.fda.gov/cder/foi/label/2007/010841s020lbl.pdf
Pennell P (2006) Evidence used to treat women with epilepsy. Epilepsia 47(1):46–53
Reynolds EH, Shorvon SD, Galbraith AW, Chadwick D, Dellaportas CI, Vydelingum L (1981) Phenytoin monotherapy for epilepsy: a long-term prospective study assisted by serum level monitoring in previously untreated patients. Epilepsia 22(4):475–488
Ropper AH, Brown RH (eds) (2005) In: Adams and Victor’s principles of neurology (online) [electronic resource]. Epilepsy and other seizure disorders, 8th edn. McGraw-Hill Medical Pub. Div., New York
Stensrud PA, Palmer H (1964) Serum phenytoin determinations in epileptics. Epilepsia 5(4):364–370
Spencer JP, Gonzalez LS, Barnhart DJ (2001) Medications in the breast-feeding mother. Am Fam Physician 64(1):119–126
Troupin AS, Ojemann LM (1975) Paradoxical intoxication: a complication of anticonvulsant administration. Epilepsia 16(5):753–758
Vore GR, Woodbury DM (1977) Phenytoin: an evaluation of several potential teratogenic mechanisms. Epilepsia 18(3):387–396
World Health Organization (2005) Atlas: epilepsy care in the world 2005 [electronic resource]. Programme for Neurological Diseases and Neuroscience, Dept. of Mental Health and Substance Abuse, World Health Organization, Geneva, pp 6–84
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag London Limited
About this entry
Cite this entry
Nemire, R.E., Ramsay, R.E. (2010). Phenytoin and Other Hydantoins. In: Panayiotopoulos, C.P. (eds) Atlas of Epilepsies. Springer, London. https://doi.org/10.1007/978-1-84882-128-6_277
Download citation
DOI: https://doi.org/10.1007/978-1-84882-128-6_277
Publisher Name: Springer, London
Print ISBN: 978-1-84882-127-9
Online ISBN: 978-1-84882-128-6
eBook Packages: MedicineReference Module Medicine